express
on 31 May 2024
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
98249014 filed on 31st Oct 2023
Registration Number
N/A
Correspondent Address
John R. Rudolph
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatolog Read More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
N/A
N/A
No 98249014
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
31st May 2024 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
31st May 2024 | ABANDONMENT - EXPRESS MAILED |
30th May 2024 | TEAS EXPRESS ABANDONMENT RECEIVED |
15th Nov 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
03rd Nov 2023 | NEW APPLICATION ENTERED |